Gastroenterology: NTC submits marketing authorisation applicat...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MILAN, April 19, 2022, /PRNewswire-AsiaNet/-- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy announces the submission of the marketing authorisation application through the European Decentralised Procedure (DCP) for its development product NTC015 (Kleerkol(R)) for bowel...
Authors: LATEST ASIANET NEWS RELEASES